Skip to main content
. 2019 Aug 2;23(10):6690–6699. doi: 10.1111/jcmm.14545

Figure 2.

Figure 2

25 VD3 ‐Probe reduced alveolar bone loss. Diabetic periodontitis models were induced, and 25(OH)2D3 or 25(OH)2D3‐probe was intraperitoneally injected. A, Bodyweight; B, fasting glucose were monitored every 2 d until sacrifice. C, Alveolar bone resorption area of the second maxilla molars was measured under the stereoscopic microscope. Yellow‐dotted areas indicate horizontal bone resorption. Data are mean ± SD (n = 8). *< .05, **< .01 compared to vehicle group